WallStreetZenWallStreetZen

NASDAQ: OBIO
Orchestra Biomed Holdings Inc Stock Ownership - Who owns Orchestra Biomed Holdings?

Insider buying vs selling

Have Orchestra Biomed Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric A. Md RoseDirector2023-05-17157$16.04
$2.52kSell
Eric A. Md RoseDirector2023-05-172,325$1.08
$2.51kBuy
Eric S. FainDirector2023-05-102,906$1.08
$3.14kBuy

1 of 1

OBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OBIO insiders and whales buy or sell their stock.

OBIO Shareholders

What type of owners hold Orchestra Biomed Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Medtronic PLC16.40%5,868,916$26.06MInsider
Rtw Investments LP15.71%5,620,645$24.96MInsider
Rtw Investments LP15.71%5,620,640$24.96MInstitution
Roderick Wong7.85%2,808,512$12.47MInsider
Perceptive Advisors LLC6.80%2,432,089$10.80MInstitution
Geoffrey Wade Smith5.19%1,855,696$8.24MInsider
Blackrock Inc4.11%1,468,768$6.52MInstitution
Vanguard Group Inc3.43%1,227,282$5.45MInstitution
David P. Hochman1.95%696,823$3.09MInsider
Darren Sherman1.74%623,445$2.77MInsider

1 of 3

OBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OBIO37.09%51.45%Net Buying
PRQR22.61%0.00%
ACHV7.96%27.78%Net SellingNet Selling
RGLS5.87%94.13%Net BuyingNet Buying
TVGN1.50%98.50%Net Selling

Orchestra Biomed Holdings Stock Ownership FAQ

Who owns Orchestra Biomed Holdings?

Orchestra Biomed Holdings (NASDAQ: OBIO) is owned by 37.09% institutional shareholders, 51.45% Orchestra Biomed Holdings insiders, and 11.46% retail investors. Medtronic PLC is the largest individual Orchestra Biomed Holdings shareholder, owning 5.87M shares representing 16.40% of the company. Medtronic PLC's Orchestra Biomed Holdings shares are currently valued at $25.76M.

If you're new to stock investing, here's how to buy Orchestra Biomed Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.